ALP Bio
ALP Bio

ALP Bio

Measured by AhrefsDR7Ahrefs DR: 7/100. Bottom 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent43Agent Readiness: 43/100. Above median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed78Site Speed: 78/100. Top 25%. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust73Data Trust: 73/100. Above median. Measured by StartupHub.ai. Median 61.

Combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development.

Website
2025ActiveSchlieren, Switzerland

About

ALP Bio AG is a Swiss biotech startup developing a platform that integrates human immune organoid biology with generative AI. Their goal is to help antibody developers identify, understand, and reduce immunogenicity risk earlier in the drug development process. The platform leverages human tonsil organoid technology to model immune activity in vitro and employs AI models to learn from biological datasets.

Competitors & Alternatives (6)

Similar companies

M
Moderna
Moderna

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Shares Biotechnology, Pharmaceuticals

DT
Degron Therapeutics
Degron Therapeutics

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Shares Biotechnology, Pharmaceuticals

A
Adcendo
Adcendo

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Shares Biotechnology, Pharmaceuticals

I
Infinimmune
Infinimmune

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Shares Biotechnology, Pharmaceuticals

C
CellCentric
CellCentric

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Shares Biotechnology, Pharmaceuticals

C
Celerion
Celerion

A global leader in clinical pharmacology and bioanalytical sciences.

Shares Biotechnology, Pharmaceuticals

Key facts

Website
alp.bio
Headquarters
Schlieren, Zurich, Switzerland
Founded
2025
Total funding
$2M (Pre-Seed)
Business model
B2B

Funding rounds

Funding rounds raised by ALP Bio
DateRoundAmountLead investors
30 Apr 2026Pre-Seed$2M42CAP

Tech stack

Detected on alp.bio, last scanned 24 Oct 2026.

Support
HubSpot
CMS / Builders
WordPress
Email provider
Google Workspace
Run your own scan

ALP Bio scores 7. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

What does ALP Bio do?

This hybrid approach aims to provide more clinically relevant signals for earlier decision-making in antibody development, supporting lead candidate screening, ADA risk stratification, and sequence optimization.

Is ALP Bio trustworthy and reputable?

StartupHub's Data Trust & Reputation score for ALP Bio is 73 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has ALP Bio raised?

ALP Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for ALP Bio